Table 2.
Associations between TCDD and TEQ-PCDD/Fs concentration and biomarker indices.
| TCDD | TEQ-PCDD/FS | ||||||
|---|---|---|---|---|---|---|---|
| Markers | N | β | 95% CI (Lower, Upper) |
p | β | 95% CI (Lower, Upper) |
p |
| Aspartate Aminotransferase (AST) | 33 | 0.414 | (0.071, 0.758) | 0.020 | 0.393 | (0.046, 0.741) | 0.028 |
| Alanine Aminotransferase (ALT) | 33 | 0.359 | (0.009, 0.709) | 0.045 | 0.349 | (−0.003, 0.702) | 0.052 |
| Gamma-Glutamyl Transpeptidase (GGT) | 33 | 0.340 | (−0.020, 0.699) | 0.063 | 0.298 | (−0.068, 0.664) | 0.107 |
| Total Bilirubin | 33 | 0.389 | (0.030, 0.748) | 0.035 | 0.283 | (−0.091, 0.656) | 0.133 |
| Glucose | 33 | −0.05 | (−0.417, 0.318) | 0.79 | −0.14 | (−0.502, 0.229) | 0.45 |
| Urea | 33 | 0.031 | (−0.318, 0.381) | 0.855 | −0.013 | (−0.364, 0.337) | 0.938 |
| Creatinin | 33 | −0.011 | (−0.284, 0.262) | 0.933 | 0.062 | (−0.211, 0.334) | 0.648 |
| Protein | 33 | 0.421 | (0.104, 0.738) | 0.011 | 0.351 | (0.021, 0.680) | 0.038 |
| Cholesterone | 33 | 0.029 | (−0.334, 0.392) | 0.871 | 0.006 | (−0.358, 0.370) | 0.974 |
| Triglyceride | 33 | 0.043 | (−0.334, 0.420) | 0.816 | 0.104 | (−0.272, 0.480) | 0.576 |
| Red Blood Cells | 33 | 0.137 | (−0.200, 0.474) | 0.412 | 0.078 | (−0.263, 0.418) | 0.644 |
| Hemoglobin | 33 | 0.003 | (−0.288, 0.294) | 0.985 | −0.024 | (−0.316, 0.267) | 0.866 |
| Leukocytes | 33 | −0.031 | (−0.420, 0.357) | 0.870 | −0.225 | (−0.605, 0.155) | 0.236 |
| Neutrocytes | 33 | −0.201 | (−0.582, 0.181) | 0.291 | −0.240 | (−0.619, 0.139) | 0.205 |
| Lymphocytes | 33 | 0.234 | (−0.146, 0.614) | 0.218 | 0.299 | (−0.075, 0.673) | 0.113 |
| Platelets | 33 | −0.172 | (−0.549, 0.206) | 0.360 | −0.127 | (−0.508, 0.254) | 0.500 |
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; PCDD/Fs, polychlorinated dibenzo-p-dioxins and polychlorinated dibenzo furans; TEQ, toxic equivalent quantity; N, number of subjects; β, standardized beta; 95% CI, 95% confidence interval. Confounding factors: gender; age; smoking status.